Agilent Technologies, Inc.
NYSE:AMedical - Diagnostics & Research
+$3.04 today
- Market cap
- $50.00B
- Beta
- 1.26
- P/E (TTM)
- 25.5
- EPS (TTM)
- $5.00
- Dividend yield
- 0.59%
Volume 2.48M
Average 2.24M
A Operating Expenses
Total costs of running the business that are not directly tied to producing goods or services sold.
Agilent Technologies, Inc.NYSE: A
Operating Expenses · Q3 FY2026 · quarter ended Jul 2026
Operating expenses grows in line with its trailing trend
Q3 FY2026 operating expenses of $598M rose 7.9% year over year, in line with the +7.9% change in trailing-twelve-month operating expenses. Sequentially, it fell 2.0% from the prior quarter. Over 3 fiscal years it compounded at +0.9% a year.
Context
- Operating expenses amounted to 31.1% of revenue in FY2025, down 0.3 pp from a year earlier.
- Operating expenses increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +7.9% toward the trailing-twelve-month pace of +7.9%.
Sources:Income StatementText generated from reported figures; not investment advice.
Operating Expenses history
USD · from the income statement
- Latest · FY2025
- 2.16B USD
- Year-over-year change
- +5.7%
- 4-year CAGR
- +1.2%
| Period | Period end | Operating Expenses | YoY change |
|---|---|---|---|
| FY2025 | 2025-10-31 | 2.16B | +5.7% |
| FY2024 | 2024-10-31 | 2.05B | -3.2% |
| FY2023 | 2023-10-31 | 2.12B | +0.5% |
| FY2022 | 2022-10-31 | 2.1B | +2.1% |
| FY2021 | 2021-10-31 | 2.06B | — |
Operating Expenses vs competitors
How A compares with its peers on the latest reported figures
- A's LTM Jul 2026 operating expenses of $2.32B is the 3rd highest of the 9 companies compared; the peer median is $1.37B.
- Its year-over-year change of +7.9% is the 3rd highest of 9, against a peer median of +3.4%.
- Operating expenses amounts to 31.5% of revenue for A, versus a peer median of 39.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $11.11B | +15.5% | -1.1% | 23.5% | |
| LTM Sep 2026 | $9.79B | +2.9% | +4.4% | 38.2% | |
| LTM Jul 2026 | $2.32B | +7.9% | +0.9% | 31.5% | |
| LTM Jul 2026 | $1.99B | +108.4% | +3.2% | 42.8% | |
| LTM Jun 2026 | $1.51B | +2.0% | +15.4% | 43.1% | |
| LTM Jun 2026 | $1.24B | +6.1% | +4.5% | 29.9% | |
| LTM Jul 2026 | $1.16B | +3.9% | +5.8% | 39.8% | |
| LTM Jun 2026 | $1.11B | -1.5% | -0.2% | 42.8% | |
| LTM Jun 2026 | $766.43M | -6.1% | -3.3% | 36.5% | |
| Peer median (excluding A) | $1.37B | +3.4% | +3.8% | 39.0% | |
Competitors are the stored peer set for A. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Oct 2021 | FY2022 Oct 2022 | FY2023 Oct 2023 | FY2024 Oct 2024 | FY2025 Oct 2025 |
|---|---|---|---|---|---|
| Revenue | 6.32B | 6.85B | 6.83B | 6.51B | 6.95B |
| Cost of Revenue | 2.91B | 3.13B | 3.37B | 2.98B | 3.31B |
| Gross Profit | 3.41B | 3.72B | 3.47B | 3.54B | 3.64B |
| Gross Margin | 53.9% | 54.4% | 50.7% | 54.3% | 52.4% |
| Research & Development | 441M | 467M | 481M | 479M | 455M |
| Selling, General & Admin | 1.62B | 1.64B | 1.63B | 1.52B | 1.71B |
| Operating Expenses | 2.06B | 2.1B | 2.12B | 2.05B | 2.16B |
| Depreciation & Amortization | 321M | 317M | 271M | 257M | 288M |
| EBITDA | 1.76B | 1.91B | 1.7B | 1.87B | 1.84B |
| EBITDA Margin | 27.9% | 27.8% | 24.9% | 28.8% | 26.4% |
| Operating Income | 1.35B | 1.62B | 1.35B | 1.49B | 1.48B |
| Operating Margin | 21.3% | 23.6% | 19.8% | 22.9% | 21.3% |
| Interest Income | 2M | 9M | 51M | 80M | 62M |
| Interest Expense | 81M | 84M | 95M | 96M | 112M |
| Other Income / Expenses | 13M | (114M) | (11M) | 33M | (44M) |
| Income Before Tax | 1.36B | 1.5B | 1.34B | 1.52B | 1.44B |
| Pre-Tax Margin | 21.5% | 22.0% | 19.6% | 23.4% | 20.7% |
| Income Tax Expense | 150M | 250M | 99M | 232M | 132M |
| Net Income | 1.21B | 1.25B | 1.24B | 1.29B | 1.3B |
| Net Margin | 19.1% | 18.3% | 18.1% | 19.8% | 18.8% |
| EPS (Basic) | 3.98 | 4.19 | 4.22 | 4.44 | 4.59 |
| EPS (Diluted) | 3.94 | 4.18 | 4.19 | 4.43 | 4.57 |
| Weighted Avg Shares | 304M | 299M | 294M | 290M | 283M |
| Weighted Avg Shares (Diluted) | 307M | 300M | 296M | 291M | 284M |
Agilent Technologies, Inc.
NYSE:A
Intrinsic Alpha fair value
Locked
Current Price
$177.33
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.